| |
|
|
|
Emmaus Life Sciences Inc.  
|
|
1.72 0.14 (0.09%) |
09-17 09:52 |
|
Open: |
1.65 |
Pre close: |
1.58 |
Target:
|
1.92 
|
|
High: |
1.72 |
Low: |
1.65 |
Resistance:
|
1.64
1.82
|
|
Volume: |
2,130 |
Market Cap: |
85M |
Support:
|
1.35
1.12
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
1.68
|
MACD |
MACD(12,26):
|
0.04 |
|
MA(20): |
1.55  |
Signal(12,26,9): |
0.03 |
|
MA(100): |
1.49 |
Stochastic Oscillator |
%K(14,3):
|
55.32 |
|
MA(250): |
1.33 |
%D(3): |
69.69 |
|
Average Volume(K) |
3-Month: |
26707
|
52-Week |
High:
|
1.89 |
|
10-Days: |
45606 |
Low: |
0.70 |
|
RSI |
RSI(14):
|
51.10 |
Change(%): |
35.0 |
|
Financials, Statistics and Valuation |
|
EPS |
-2.089 |
Return on Equity (ttm) |
0.0 |
Shares Out. (M) |
48.99 |
|
EPS Est. Current Year |
0.000 |
Return on Assets (ttm) |
-2.0 |
Shares Float (M) |
33.96 |
|
EPS Est. Next Year |
0.000 |
PEG Ratio |
0.00 |
% Held by Insiders |
40.64 |
|
EPS Est. Next Quarter |
0.000 |
Qtrly Rev. Growth |
24.6 |
% Held by Institutions |
0.00 |
|
Forward EPS |
-1.650 |
Gross Profit (p.s.) |
0.442 |
Shares Short (K) |
41 |
|
Book Value (p.s.) |
-0.370 |
EBITDA (p.s.) |
-0.042 |
P/E |
-0.76 |
|
Sales Per Share |
0.464 |
Qtrly Earnings Growth |
0.00 |
P/BV |
-4.27 |
|
Profit Margin |
-241.04 |
Operating Cash Flow
(M) |
-4.52 |
P/S |
3.40 |
|
Operating Margin |
-9.28 |
Levered Free Cash Flow
(M) |
-0.40 |
P/CF |
-17.12 |
|
|
|
|
|
|
